[Federal Register Volume 74, Number 33 (Friday, February 20, 2009)]
[Notices]
[Page 7924]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-3646]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 8, 2009, Sigma 
Aldrich Research Biochemicals, Inc., 1-3 Strathmore Road, Natick, 
Massachusetts 01760-2447, made application by renewal to the Drug 
Enforcement Administration (DEA) as a bulk manufacturer of the basic 
classes of controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)............................  I
Methcathinone (1237)........................  I
Aminorex (1585).............................  I
Gamma Hydroxybutyric Acid (2010)............  I
Alpha-ethyltryptamine (7249)................  I
Lysergic acid diethylamide (7315)...........  I
Tetrahydrocannabinols (7370)................  I
4-Bromo-2,5-dimethoxyamphetamine (7391).....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)..  I
2,5-Dimethoxyamphetamine (7396).............  I
3,4-Methylenedioxyamphetamine (7400)........  I
N-Hydroxy-3,4-methylenedioxyamphetamine       I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine (7404)  I
3,4-Methylenedioxymethamphetamine (MDMA)      I
 (7405).
Psilocybin (7437)...........................  I
5-Methoxy-N,N-diisopropyltryptamine (7439)..  I
1-[1-(2-Thienyl)cyclohexyl]piperidine (TCP)   I
 (7470).
1-Benzylpiperazine (BZP) (7493).............  I
Heroin (9200)...............................  I
Normorphine (9313)..........................  I
Amphetamine (1100)..........................  II
Methamphetamine (1105)......................  II
Nabilone (7379).............................  II
1-Phenylcyclohexylamine (7460)..............  II
Phencyclidine (7471)........................  II
Cocaine (9041)..............................  II
Codeine (9050)..............................  II
Diprenorphine (9058)........................  II
Ecgonine (9180).............................  II
Levomethorphan (9210).......................  II
Levorphanol (9220)..........................  II
Meperidine (9230)...........................  II
Metazocine (9240)...........................  II
Methadone (9250)............................  II
Morphine (9300).............................  II
Thebaine (9333).............................  II
Levo-alphacetylmethadol (9648)..............  II
Carfentanil (9743)..........................  II
Fentanyl (9801).............................  II
------------------------------------------------------------------------

    The company plans to manufacture reference standards.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than April 21, 2009.

    Dated: February 13, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E9-3646 Filed 2-19-09; 8:45 am]
BILLING CODE 4410-09-P